These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 11797704)
21. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products. Lang L Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067 [No Abstract] [Full Text] [Related]
22. FDA panel gives cautious signal to summit. Moretti M J Refract Corneal Surg; 1994; 10(6):613-4. PubMed ID: 7719529 [No Abstract] [Full Text] [Related]
23. The FDA and the spine surgeon. Ducker TB J Spinal Disord; 1999 Aug; 12(4):277-9. PubMed ID: 10451041 [No Abstract] [Full Text] [Related]
24. FDA user fee and Modernisation Act. Donawa M Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526 [TBL] [Abstract][Full Text] [Related]
25. Devices and the food and drug administration. Phillips SJ; Phillips RS Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210 [No Abstract] [Full Text] [Related]
26. A pivotal medical-device case. Picca SM N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426011 [No Abstract] [Full Text] [Related]
27. The medical device safety act of 2009: clarifying preemption. Turcott RG; Ashley EA Am J Ther; 2009; 16(6):471-4. PubMed ID: 19940607 [No Abstract] [Full Text] [Related]
28. Two intravascular brachytherapy systems approved by FDA. SoRelle R Circulation; 2000 Nov; 102(21):E9041-3. PubMed ID: 11185473 [No Abstract] [Full Text] [Related]
29. Remarks by the Commissioner of Food and Drugs at the twentieth anniversary celebration of the 1976 Medical Device Amendments. Kessler DA Food Drug Law J; 1996; 51(4):501-3. PubMed ID: 11797727 [No Abstract] [Full Text] [Related]
30. User fees and medical device reviews. Lewis C FDA Consum; 2003; 37(2):18-9. PubMed ID: 12715765 [No Abstract] [Full Text] [Related]
31. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage. Flaherty JM Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643 [No Abstract] [Full Text] [Related]
32. Remarks by the Honorable Paul Rogers at the twentieth anniversary celebration of the 1976 Medical Device Amendments. Rogers PG Food Drug Law J; 1996; 51(4):505-7. PubMed ID: 11797728 [No Abstract] [Full Text] [Related]
34. Combination products regulation at the FDA. Lauritsen KJ; Nguyen T Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151 [TBL] [Abstract][Full Text] [Related]
35. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion. Surprenant JA Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554 [TBL] [Abstract][Full Text] [Related]
37. The new FDA combination products programme. Donawa M Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330 [TBL] [Abstract][Full Text] [Related]
38. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule. Food and Drug Administration, HHS Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946 [TBL] [Abstract][Full Text] [Related]
39. A pivotal medical-device case. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2008 Jan; 358(1):76-7. PubMed ID: 18172178 [No Abstract] [Full Text] [Related]